ClinVar Miner

Submissions for variant NM_000289.6(PFKM):c.1413-64A>G

dbSNP: rs1202417178
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001387777 SCV001588493 pathogenic Glycogen storage disease, type VII 2023-08-29 criteria provided, single submitter clinical testing This sequence change falls in intron 15 of the PFKM gene. It does not directly change the encoded amino acid sequence of the PFKM protein. RNA analysis indicates that this variant induces altered splicing and likely results in the gain of 21 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with glycogen storage disease type VII (PMID: 8659544). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as intron 16 (G-64A). ClinVar contains an entry for this variant (Variation ID: 1074469). Studies have shown that this variant results in the activation of a cryptic splice site in intron 15 (PMID: 8659544). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.